Simultaneous voltammetric immunodetection of alpha-fetoprotein and glypican-3 using a glassy carbon electrode modified with magnetite-conjugated dendrimers
- PMID: 30904972
- DOI: 10.1007/s00604-019-3354-4
Simultaneous voltammetric immunodetection of alpha-fetoprotein and glypican-3 using a glassy carbon electrode modified with magnetite-conjugated dendrimers
Abstract
The authors describe an electrochemical immunoassay for simultaneous determination of alpha-fetoprotein (AFP) and glypican-3 (GPC-3) which are important biomarkers for early detection of hepatocellular carcinoma (HCC). Magnetite (Fe3O4) nanoparticles (NPs) were decorated with hyperbranched amino functionalized dendrimers. The modified NPs were coupled to the antibodies against AFP and GPC-3. The electrochemical behaviour of the Fe3O4 NPs and dendrimer-modified NPs were studied. A glassy carbon electrode was then modified with the NP-conjugated antibodies and biomolecular interactions were studied by using cyclic voltammetry and electrochemical impedance spectroscopy. Dual differential pulse voltammetric sensing was performed by utilizing the redox probes; Prussian blue for AFP and toluidine blue for GPC-3. The biomarkers can be detected best at voltages of 0.25 mV and - 0.54 mV (vs Ag/AgCl) for AFP and GPC-3, respectively. The low working potentials makes the method more selective over other electroactive species present in real human serum samples. Response is linear in 0.02 to 10 ng mL-1 concentration ranges of both AFP and GPC-3; and the respective detection limits are 50 and 70 pg mL-1. The method was validated by analysing spiked human serum samples. In our perception, the method is of great clinical significance as combination of GPC-3 and AFP increases the sensitivity of detection of HCC. Graphical abstract Schematic presentation of polyamidoamine (PAMAM) dendrimers modified magnetite (Fe3O4) nanoparticles as electrochemical sensing platform using redox dyes Prussian blue and toluidine blue for simultaneous detection of alpha-fetoprotein (AFP) and glypican-3 (GPC-3), respectively by differential pulse voltammetry.
Keywords: AFP; Biosensor; Cyclic voltammetry; Differential pulse voltammetry; Electrochemical impedance spectroscopy; Fe3O4 nanoparticles; GPC-3; Hepatocellular carcinoma; PAMAM dendrimer; Simultaneous detection.
Similar articles
-
Au nanoparticles/PAMAM dendrimer functionalized wired ethyleneamine-viologen as highly efficient interface for ultra-sensitive α-fetoprotein electrochemical immunosensor.Biosens Bioelectron. 2014 Sep 15;59:389-96. doi: 10.1016/j.bios.2014.03.049. Epub 2014 Mar 30. Biosens Bioelectron. 2014. PMID: 24755256
-
Labeled sandwich-type electrochemical immunosensor based on Ti3C2Tx/AuNP and Ti3C2Tx/HKUST-1/TB composites for early liver cancer detection.Mikrochim Acta. 2024 Aug 27;191(9):565. doi: 10.1007/s00604-024-06618-4. Mikrochim Acta. 2024. PMID: 39192061
-
Prussian blue nanoparticle-labeled aptasensing platform on graphene oxide for voltammetric detection of α-fetoprotein in hepatocellular carcinoma with target recycling.Analyst. 2019 Aug 21;144(16):4858-4864. doi: 10.1039/c9an01029g. Epub 2019 Jul 11. Analyst. 2019. PMID: 31294738
-
Electrochemical immuno-biosensors for the detection of the tumor marker alpha-fetoprotein: A review.Talanta. 2024 May 1;271:125638. doi: 10.1016/j.talanta.2024.125638. Epub 2024 Jan 18. Talanta. 2024. PMID: 38237279 Review.
-
Detection of Alpha-Fetoprotein Using Aptamer-Based Sensors.Biosensors (Basel). 2022 Sep 21;12(10):780. doi: 10.3390/bios12100780. Biosensors (Basel). 2022. PMID: 36290918 Free PMC article. Review.
Cited by
-
Targeting Glypican-3 for Liver Cancer Therapy: Clinical Applications and Detection Methods.J Clin Transl Hepatol. 2025 Aug 28;13(8):665-681. doi: 10.14218/JCTH.2025.00099. Epub 2025 Aug 7. J Clin Transl Hepatol. 2025. PMID: 40862283 Free PMC article. Review.
-
Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview.Diagnostics (Basel). 2024 Jul 15;14(14):1519. doi: 10.3390/diagnostics14141519. Diagnostics (Basel). 2024. PMID: 39061656 Free PMC article. Review.
-
Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.World J Clin Cases. 2022 Apr 16;10(11):3321-3333. doi: 10.12998/wjcc.v10.i11.3321. World J Clin Cases. 2022. PMID: 35611205 Free PMC article. Review.
-
B3galt5 deficiency attenuates hepatocellular carcinoma by suppressing mTOR/p70s6k-mediated glycolysis.Cell Mol Life Sci. 2022 Dec 10;80(1):8. doi: 10.1007/s00018-022-04601-x. Cell Mol Life Sci. 2022. PMID: 36495345 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous